ICV

China's New Energy Sector Breaks 20 Million Vehicles, as the Hyper GT Takes on the Model 3

Retrieved on: 
Tuesday, July 4, 2023
Atmos, Acceleration, ICV, Aion Hyper GT, EV, Bev, AEP, Terrex ICV, Torque, Electricity, Information technology, Multimedia, LCD, EVS, AION, Ministry, Ministry of Industry and Information Technology, High fidelity, GAC, Growth, Nappa, Dolby Atmos, RMB, NVH, Renewable energy, Electric battery, Fireworks, Rail transport, Hyper

The record-setting model in question is the Hyper GT, a high-end electric sedan under Hyper, AION's new premium marque, produced in the company's intelligent manufacturing base in Guangzhou, China.

Key Points: 
  • The record-setting model in question is the Hyper GT, a high-end electric sedan under Hyper, AION's new premium marque, produced in the company's intelligent manufacturing base in Guangzhou, China.
  • The achievement of China achieving the milestone of 20 million new energy vehicle has left the European and American industry astounded by the remarkable pace of development and incredible technological advancements in the Chinese new energy automotive industry.
  • The Hyper GT boasts a powerful combination of features that makes it a strong contender in the premium market for new energy sedans.
  • The arrival of Hyper GT as the 20 millionth new energy vehicle in China reflects AION's dominant capabilities in developing top quality and innovation-driven electric cars.

UAE’s In-Country Value Projects Driving Billions to Local Firms

Retrieved on: 
Thursday, June 1, 2023
Other Manufacturing, Finance, Transport, Business, Professional Services, Manufacturing, Logistics, Supply Chain Management, Retail, Make, ICV, Private sector, Partnership, Industrialisation, Hydrogen, Abu Dhabi Department of Education and Knowledge, Multimedia, ADNOC, Carbon, Language, Government, Assistant, Ministry, GDP, Economic development, Ministry of Industry and Advanced Technology (United Arab Emirates), Drug, Renewable energy

More than $27.23 billion has been redirected to the local economy since the UAE Ministry of Industry and Advanced Technology (MoIAT) and ADNOC launched major in-country value programs to support domestic industries.

Key Points: 
  • More than $27.23 billion has been redirected to the local economy since the UAE Ministry of Industry and Advanced Technology (MoIAT) and ADNOC launched major in-country value programs to support domestic industries.
  • “The National In-Country Value Program is a nationwide program that speaks one language across many different sectors,” HE said.
  • Local industrial leaders described how they are utilizing alternative energy resources such as solar and hydrogen to reduce their carbon footprint.
  • The second edition of the Make it in the Emirates Forum concluded on Thursday with the UAE showcasing its unique value proposition to international investors.

NetEase Cloud Music Launches Dolby Atmos for Vast Music Contents and Scenarios

Retrieved on: 
Friday, May 19, 2023
Cloud, Atmos, MUNA, NetEase Cloud Music, Music, HKEX, Intelligence, Dolby Atmos, ICV, Catalog, Cassette tape

HANGZHOU, China, May 19, 2023 /PRNewswire/ -- Cloud Music Inc. (HKEX: 9899, "NetEase Cloud Music" or the "Company"), a leading interactive music streaming service provider in China, recently announced it now supports Dolby Atmos® across its vast music library and scenarios, making premium immersive listening experiences more accessible to music fans across China.

Key Points: 
  • HANGZHOU, China, May 19, 2023 /PRNewswire/ -- Cloud Music Inc. (HKEX: 9899, "NetEase Cloud Music" or the "Company"), a leading interactive music streaming service provider in China, recently announced it now supports Dolby Atmos® across its vast music library and scenarios, making premium immersive listening experiences more accessible to music fans across China.
  • With this update in its Dolby Atmos offering, NetEase Cloud Music is providing music enthusiasts with an immersive audio experience that brings out more depth, clarity, and details in their favorite music.
  • NetEase Cloud Music also plans to bring more premium content from top-tier musicians in Dolby Atmos to more scenarios, including the home music space and Intelligent Connected Vehicles (ICVs) throughout the rest of this year.
  • Introducing spatial audio ft. Dolby Atmos, now available on NetEase Cloud Music", said Sam Smith.

CANbridge and UMass Chan Medical School Spinal Muscular Atrophy Gene Therapy (CAN203) Improves Lifespan and Motor Function in Mice When Administered via Intracerebroventricular Injection

Retrieved on: 
Thursday, May 18, 2023
Neurology, Biotechnology, Pharmaceutical, General Health, Health, University, Genetics, Education, Tissue, SMN, ICV, SMA, Mouse, Central nervous system, University of Massachusetts, Gene, Spinal cord, Survival, SMN1, Toxicity, Research, Doctor of Philosophy, AAV, CNS, Brain cell, Patient, Dorsal root ganglion, Cell, DRG, Intracerebroventricular injection, American Society of Gene and Cell Therapy, IND, Society, Microbiology, Vaccine

The benchmark vector is identical in design to the only approved gene therapy for SMA.

Key Points: 
  • The benchmark vector is identical in design to the only approved gene therapy for SMA.
  • Furthermore, the second-generation gene therapy resulted in higher levels of SMN protein in the central nervous system (CNS), particularly within motor neurons, and lower expression in the peripheral tissues, compared to benchmark vector-treated mice.
  • Superior transgene expression was observed in disease-vulnerable cells, including ChAT-positive motor neurons in the spinal cord.
  • No evidence of DRG toxicity associated with superior SMN expression was observed at 90 days after ICV injection with the high dose of the second-generation gene therapy.

CANbridge-UMass Chan Medical School Spinal Muscular Atrophy Gene Therapy Animal Data to be Presented at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting

Retrieved on: 
Wednesday, May 3, 2023
Science, Biotechnology, Research, Pharmaceutical, Oncology, Health, Genetics, Clinical Trials, Tissue, Abstract (summary), ICV, SMA, University of Massachusetts, Gene, IV, Spinal muscular atrophy, SMN1, Doctor of Philosophy, AAV, Weight gain, MD, Cell, American Society of Gene and Cell Therapy, Society, Pharmaceutical industry, Vaccine

The study reports that a novel second-generation hSMN1-AAV gene therapy vector, consisting of an endogenous SMN1 promoter and codon-optimized human SMN1 transgene in two different AAV serotypes, outperformed the benchmark gene therapy across several endpoints, including lifespan, weight gain and motor functions, in a mouse model of spinal muscular atrophy (SMA) when administered via intracerebroventricular (ICV) delivery.

Key Points: 
  • The study reports that a novel second-generation hSMN1-AAV gene therapy vector, consisting of an endogenous SMN1 promoter and codon-optimized human SMN1 transgene in two different AAV serotypes, outperformed the benchmark gene therapy across several endpoints, including lifespan, weight gain and motor functions, in a mouse model of spinal muscular atrophy (SMA) when administered via intracerebroventricular (ICV) delivery.
  • Furthermore, when delivered via ICV at one-tenth the dose used in both high- and low-dose cohorts in an earlier IV study, the second-generation gene therapy produced similar lifespan and body weight gains and improved motor functions.
  • The benchmark therapy uses a vector similar to that used in the only gene therapy approved for SMA.
  • “We believe that the transgene expression in our second-generation SMA gene therapy better mimics the natural physiological levels of SMN1 in transduced tissues.

Taysha Gene Therapies Announces Presentation on New Preclinical Data for TSHA-102 in Rett Syndrome at Upcoming American Society of Gene and Cell Therapy 26th Annual Meeting

Retrieved on: 
Thursday, April 27, 2023
University of Texas Southwestern Medical Center, ICV, Central nervous system, University, Gene, MECP2, Rett syndrome, Neurodevelopmental disorder, American Society of Gene and Cell Therapy, AAV, CNS, Model, Behavior, Survival, Cell, Society, RTT

DALLAS, April 27, 2023 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system (CNS), today announced that an abstract related to its TSHA-102 program in Rett syndrome was accepted for presentation at the upcoming American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting, taking place in Los Angeles, CA from May 16-20, 2023.

Key Points: 
  • DALLAS, April 27, 2023 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system (CNS), today announced that an abstract related to its TSHA-102 program in Rett syndrome was accepted for presentation at the upcoming American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting, taking place in Los Angeles, CA from May 16-20, 2023.
  • The abstract includes new preclinical data from a Taysha-sponsored study for TSHA-102, a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome, a rare neurodevelopmental disorder caused by mutations in the X-linked MECP2 gene.
  • Details for the presentation are as follows:
    Abstract Title: A Human-Ready Regulated AAV9/miniMECP2-miRARE Gene Therapy (TSHA-102) Improves Survival, Weight, and Behavior After Intracerebroventricular (ICV) Dosing in the Neonatal Knockout Rett (RTT) Mouse Model
    Presenter: Sarah Sinnett, Ph.D., University of Texas Southwestern Medical Center, Co-Inventor of miRARE technology

Wave Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Retrieved on: 
Wednesday, March 22, 2023
PRISM, 50/50 (2011 film), Takeda, C9orf72, MBA, Cerebrospinal fluid, Protein, MD, Observation, RNA interference, DSM-IV codes, Disease, Duchenne muscular dystrophy, Therapy, Genetics, Aimer, Pharmacokinetics, Mutation, Research, Gene expression, Small RNA, AATD, N-Acetylgalactosamine, Episcopal conference, Muscular Dystrophy Association, Sirna Therapeutics, Liver, MDA, IND, Conference, Safety, GSK, SERPINA1, Messenger, Webcast, APP, RNA editing, HD, ICV, Central nervous system, Q&A, Genomics, RNA, CNS, CTAS, DMD, Mouse, Pharmaceutical industry, Broadcasting, Vaccine, Cryptocurrency, Video game, Wave

ET today

Key Points: 
  • ET today
    CAMBRIDGE, Mass., March 22, 2023 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, today announced financial results for the fourth quarter and full year ended December 31, 2022 and provided a business update.
  • Research and development expenses were $31.1 million in the fourth quarter of 2022 as compared to $25.8 million in the same period in 2021.
  • As of December 31, 2022, Wave had $88.5 million in cash and cash equivalents, as compared to $150.6 million as of December 31, 2021.
  • ET to discuss the fourth quarter and full year 2022 financial results and provide a business update.

Grace, Sohar University and OQ Inaugurate First DCR™ Pilot Plant in Oman

Retrieved on: 
Thursday, March 16, 2023
Research, ICV, Partnership, FCC, Fluid catalytic cracking, Plastic, Woman, Education, OQ, Sohar University, W. R. Grace and Company, Grace, University, Interior design, Fine chemical

"It's very exciting to move this 15-year partnership between Grace, Sohar University, and OQ to the next level with the installation and commissioning of a Grace DCR™ Pilot Plant," said Grace CEO Bob Patel.

Key Points: 
  • "It's very exciting to move this 15-year partnership between Grace, Sohar University, and OQ to the next level with the installation and commissioning of a Grace DCR™ Pilot Plant," said Grace CEO Bob Patel.
  • The Grace DCR™ Pilot Plant, which is an important part of Oman’s Vision 2040, is a proprietary circulating riser pilot Fluid Catalytic Cracking (FCC) unit and the leading, commercially available technology for small-scale FCC pilot units.
  • Oman energy company OQ and other regional refiners are able to maximize value from existing, new and unconventional feeds by conducting research using a pilot plant.
  • The DCR™ Pilot Plant and Ecat Lab in which it operates are 100% staffed by Omani nationals, of whom 75% are women.

ICV Partners Announces Formation of Desi Fresh Foods

Retrieved on: 
Tuesday, February 21, 2023
Piper, McDermott Will & Emery, Latham & Watkins, Acquisition, DLA Piper, Kraft Foods, Food group, The Company, Desi, United, Lazard, Latham, Marketing, Growth, Health, M&T Bank, Drink, ICV, Food, Financial adviser, Food delivery, Beiersdorf

Desi Fresh Foods is the leading producer of dahi, or South Asian yogurt, and lassi, a drinkable south Asian yogurt, in the United States.

Key Points: 
  • Desi Fresh Foods is the leading producer of dahi, or South Asian yogurt, and lassi, a drinkable south Asian yogurt, in the United States.
  • Desi Fresh Foods growth has outpaced the growth of the South Asian population and appeals to the broadening American consumer's palate.
  • Prior to Desi Fresh Foods, Mr. LaPorta was an executive in marketing and operating roles at Beiersdorf, Revlon, and Kraft Foods.
  • "My team and I are thrilled with the growth opportunities that are in front of us at Desi Fresh Foods.

Automotive CMOS Image Sensor (CIS) Chip Industry Research Report 2022: Intelligent Vehicles Provide Lucrative Opportunities - ResearchAndMarkets.com

Retrieved on: 
Monday, February 13, 2023
Technology, Hardware, Automotive Manufacturing, Manufacturing, ASIL, LFM, Photography, OMS, Smartphone, TANK, SVS, MP, ADAS, CSP, Level 2, Certification, Temperature, CIS, Child, Backup camera, OmniVision Technologies, HDR, Yole, RVC, Vital signs, Growth, CES, DMS, ICV, Camera, Satellite navigation device

The "Automotive CMOS Image Sensor (CIS) Chip Industry Research Report, 2022" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Automotive CMOS Image Sensor (CIS) Chip Industry Research Report, 2022" report has been added to ResearchAndMarkets.com's offering.
  • It is known that the biggest application market of image sensor is smartphone field.
  • As the smartphone market becomes saturated, image sensor chip vendors are turning to booming intelligent vehicle market.
  • The huge demand also drives the growth of automotive image sensors and gives rise to more market segments.